Implications of immunomodulatory interleukins for the hyperimmunoglobulinemia of Sjögren's syndrome

Cellular Immunology

Volumn 259, Issue 1, 2009, Pages 56-60

  Giron Gonzalez J A ^a   Baturone, R ^a   Soto, M J ^a   Marquez M ^a   Macias I ^a   Montes de Oca, M ^a   Medina, F ^a   Chozas, N ^a   Garcia Perez S ^a  

^a HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Hypergammaglobulinemia; Monoclonal gammopathy; Sj gren's syndrome; Th1 and Th2 cytokines

Indexed keywords

CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN DERIVATIVE;

ADULT; AGED; ARTICLE; B LYMPHOCYTE DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; GAMMOPATHY; HUMAN; HYPERIMMUNOGLOBULINEMIA; IMMUNOMODULATION; MACROPHAGE; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; SJOEGREN SYNDROME; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; FEMALE; HUMANS; HYPERGAMMAGLOBULINEMIA; IMMUNOGLOBULINS; INTERLEUKINS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN ARRAY ANALYSIS; SJOGREN'S SYNDROME;

EID: 68549101541     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2009.05.013     Document Type: Article

References (32)

1. Fox P.C. Autoimmune diseases and Sjögren's syndrome: an autoimmune exocrinopathy. Ann. N. Y. Acad. Sci. 1098 (2007) 15-21
2. Asmussen K., Andersen V., Bendixen G., Schiodt M., and Oxholm P. A new model for classification of disease manifestations in primary Sjögren's syndrome: evaluation in a retrospective long-term study. J. Int. Med. 239 (1996) 475-482
3. Sugai S., Shimizu S., and Konda S. Lymphoproliferative disorders in Japanese patients with Sjögren's syndrome. Scand. J. Rheumatol. Suppl. 61 (1986) 118-122
4. Walters M.T., Stevenson F.K., Herbert A., Cawley M.I., and Smith J.L. Lymphoma in Sjogren's syndrome: urinary monoclonal free light chains as a diagnostic aid and a means of tumour monitoring. Scand. J. Rheumatol. Suppl. 61 (1986) 114-117
5. Sugai S., Shimizu S., Tachibana J., Imaoka S., and Konda S. A high incidence of rheumatoid factor idiotypes in monoclonal proteins in the serum and in lymphoma cells in patients with Sjögren's syndrome. J. Autoimmun. 2 (1989) 471-476
6. Tzioufas A.G., Boumba D.S., Skopouli F.N., and Moutsopoulos H.M. Mixed monoclonal cryoglobulinemia and monoclonal rheumatoid factor crossreactive idiotypes as predictive factors for the development of lymphoma in primary Sjögren's syndrome. Arthritis Rheum. 39 (1996) 767-772
7. Moutsopoulos H.M., Steinberg A.D., Fauci A.S., Lane H.C., and Papadopoulos N.M. High incidence of free monoclonal lambda light chains in the sera of patients with Sjögren's syndrome. J. Immunol. 130 (1983) 2663-2665
8. Brito-Zeron P., Ramos-Casals M., Nardi N., Cervera R., Yagüe J., Ingelmo M., and Font J. Circulating monoclonal immunoglobulins in Sjögren's syndrome. Prevalence and clinical significance in 237 patients. Medicine (Baltimore) 84 (2005) 90-97
9. Harding F.A., McArthur J.G., and Gross J.A. CD-28 mediated signalling co-stimulates murine T cells and prevents induction of anergy T-cell clones. Nature 356 (1992) 607-609
10. Thompson C.B., Lindsten T., Ledbetter J.A., Kunkel S.L., Young H.A., Emerson S.G., Leiden J.M., June C.H., et al. CD28 activation pathway regulates the production of multiple T-cell derived lymphokines/cytokines. Proc. Natl. Acad. Sci. USA 86 (1989) 1333-1337
11. Mosmann T.R., and Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17 (1996) 138-146
12. Mosmann T.R., and Moore K.W. The role of IL-10 in crossregulation of TH1 and TH2 responses. Immunol. Today 12 (1991) 49-53
13. Powrie F., and Coffman R. Cytokine regulation of T-cell function: potential for therapeutic intervention. Immunol. Today 14 (1993) 270-274
14. Vitali C., Bombardieri S., Jonsson R., Moutsopoulos H.M., Alexander E.L., Carsons S.E., Daniels T.E., Fox P.C., Fox R.I., Kassan S.S., Pillemer S.R., Talal N., and Weisman M.H. European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann. Rheum. Dis. 61 (2002) 554-558
15. Chishom D.M., and Mason D.K. Labial salivary gland biopsy in Sjögren's disease. J. Clin. Pathol. 21 (1968) 656-660
16. Kassan S.S., and Moutsopoulos H.M. Clinical manifestations and early diagnosis of Sjögren's syndrome. Arch. Intern. Med. 164 (2004) 1275-1284
17. Mosser D.M. The many faces of macrophage activation. J. Leuk. Biol. 73 (2003) 209-212
18. Watford W.T., Moriguchi M., Morinobu A., and O'Shea J.J. The biology of IL-12: coordinating innate and adaptive immune responses. Cytokine Growth Factor Rev. 14 (2003) 361-368
19. Szodoray P., Alexy P., Brunz J.G., Centolay M., and Jonsson R. Circulating cytokines in primary Sjögren's syndrome determined by a multiplex cytokine array system. Scand. J. Immunol. 59 (2004) 592-599
20. Garcia-Carrasco M., Font J., Filella X., Cervera R., Ramos-Casals M., Sisó A., Aymamí A., Ballesta A.M., and Ingelmo M. Circulating levels of Th1/Th2 cytokines in patients with primary Sjögren's syndrome: correlation with clinical and immunological features. Clin. Exp. Rheumatol. 19 (2001) 411-415
21. Halse A., Tengner P., Wahren-Herlenius M., Haga H., and Jonsson R. Increased frequency of cells secreting interleukin-6 and interleukin-10 in peripheral blood of patients with primary Sjögren's syndrome. Scand. J. Immunol. 49 (1999) 533-538
22. Hagiwara E., Pando J., Ishigatsubo Y., and Klinman D.M. Altered frequency of type 1 cytokine secreting cells in the peripheral blood of patients with primary Sjögren's syndrome. J. Rheumatol. 25 (1998) 89-93
23. Kohriyama K., and Katayama Y. Disproportion of helper T cell subsets in peripheral blood of patients with primary Sjögren's syndrome. Autoimmunity 32 (2000) 67-72
24. Perrier S., Serre A., Dubost J., Beaujon G., Plazonnet M.P., Albuisson E., and Sauvezie B. Increased serum levels of interleukin 10 in Sjögren's syndrome; correlation with increased IgG1. J. Rheumatol. 27 (2000) 935-939
25. Eriksson P., Andersson C., Ekerfelt C., Ernerudh J., and Skogh T. Sjögren's syndrome with myalgia is associated with subnormal secretion of cytokines by peripheral blood mononuclear cells. J. Rheumatol. 31 (2004) 729-735
26. Ozaki Y., Amakawa R., Ito T., Iwai H., Tajima K., Uehira K., Kagawa H., Uemura Y., Yamashita T., and Fukuhara S. Alteration of peripheral blood dendritic cells in patients with primary Sjögren's syndrome. Arthritis Rheum. 44 (2001) 419-431
27. Szodoray P., Alex P., Jonsson M.V., Knowlton N., Dozmorov I., Nakken B., Delaleu N., Jonsson R., and Centola M. Distinct profiles of Sjögren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF. Clin. Immunol. 117 (2005) 168-176
28. Koarada S., Haruta Y., Mitamura M., Morito F., Tada Y., Ohta A., and Nagasawa K. Ex vivo CD41 T-cell cytokine expression from patients with Sjögren's syndrome following in vitro stimulation to induce proliferation. Rheumatology 45 (2006) 392-399
29. Romagnani S. Regulation of the T cell response. Clin. Exp. Allergy 36 (2006) 1357-1366
30. De Carli M., D'Elios M.M., Zancuoghi G., Romagnani S., and Del Prete G. Human Th1 and Th2 cells: functional properties, regulation of development and role in autoimmunity. Autoimmunity 18 (1994) 301-308
31. Yoshizaki K., Kuritani T., and Kishimoto T. Interleukin-6 in autoimmune disorders. Semin. Immunol. 4 (1992) 155-166
32. Rousset F., Garcia E., Defrance T., Péronne C., Vezzio N., Hsu D.H., Kastelein R., Moore K.W., and Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 89 (1992) 1890-1893